In March (March 2025), Viking Therapeutics signed a multi-year contract with the CDMO CordenPharma to provide development and manufacturing services for clinical and commercial scale (drug substance and drug product) of VK2735 for both the subcutaneous and oral peptide formulations.
Distribution channels encompass online platforms, retail outlets, and direct sales, with margin control points at formulation, branding, and distribution stages
With solid growth in non-GLP-1 (+30%) and the expansion into Europe with the ZAVA acquisition, I don't see the long-term investment case hurt
The simplest way to think about it If you are specifically wondering about lemon bottle vs cryolipolysis , cryolipolysis tends to be the more predictable option for body contouring at scale, while Lemon Bottle tends to be the more niche option for detailed targeting
Twice-Weekly Is It Safe to Split Your Dose
Strategic cycling between treatment periods and intensive lifestyle maintenance provides another approach for those with limited financial resources